PSCH Among Health Care ETFs
End-of-day Nov 18, 2026 · 27 Health care ETFs by 5Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | +0.7% | −2.8% | +4.4% | +1.5% | +27.4% | +34.2% | +59.2% | −11.0% | +154.2% | +592.8% |
| Peer average | −0.9% | −5.3% | −1.4% | −2.4% | +17.0% | +21.8% | +68.8% | +23.4% | +169.9% | — |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$49 of every $1,000 in PSCH is TG
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | TGTXTG Therapeutics | Healthcare | 4.89% | $489.19 | 145K | $9.1M |
| 2 | PTGXProtagonist Therapeutics | Healthcare | 4.44% | $443.64 | 66K | $8.3M |
| 3 | ALKSAlkermes | Healthcare | 4.19% | $419.32 | 172K | $7.8M |
| 4 | TFXTeleflex | Healthcare | 3.72% | $371.79 | 43K | $6.9M |
| 5 | SUPNSupernus | Healthcare | 3.31% | $331.44 | 212K | $6.2M |
| 6 | LGNDLigand Pharmaceuticals | Healthcare | 3.22% | $322.12 | 20K | $6.0M |
| 7 | RDNTRadNet | Healthcare | 2.92% | $291.82 | 72K | $5.4M |
| 8 | MMSIMerit Medical Systems | Healthcare | 2.77% | $277.44 | 61K | $5.2M |
| 9 | PTCTPTC Therapeutics | Healthcare | 2.77% | $277.04 | 85K | $5.2M |
| 10 | CONConcentra Group Parent | Healthcare | 2.76% | $276.39 | 121K | $5.1M |
| 11 | LFSTLifeStance Health Group | Healthcare | 2.45% | $244.52 | 321K | $4.5M |
| 12 | ICUIICU Medical | Healthcare | 2.43% | $243.29 | 26K | $4.5M |
| 13 | LQDALiquidia | Healthcare | 2.32% | $231.78 | 76K | $4.3M |
| 14 | —Cash & Equivalents | — | 2.28% | $228.02 | 4.2M | $4.2M |
| 15 | AMRXAmneal Pharmaceuticals | Healthcare | 2.14% | $214.40 | 189K | $4.0M |
of the $112B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | TGTX | TG Therapeutics | 4.89% |
| 2 | PTGX | Protagonist Therapeutics | 4.44% |
| 3 | ALKS | Alkermes | 4.19% |
| 4 | TFX | Teleflex | 3.72% |
| 5 | SUPN | Supernus | 3.31% |
| 6 | LGND | Ligand Pharmaceuticals | 3.22% |
| 7 | RDNT | RadNet | 2.92% |
| 8 | MMSI | Merit Medical Systems | 2.77% |
| 9 | PTCT | PTC Therapeutics | 2.77% |
| 10 | CON | Concentra Group Parent | 2.76% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Mar 23, 2026 | Mar 27, 2026 | $0.0003 |
| Sep 22, 2025 | Sep 26, 2025 | $0.0026 |
| Jun 23, 2025 | Jun 27, 2025 | $0.0020 |
| Mar 24, 2025 | Mar 28, 2025 | $0.0142 |
| Dec 23, 2024 | Dec 27, 2024 | $0.0180 |
| Jun 24, 2024 | Jun 28, 2024 | $0.0659 |
| Mar 18, 2024 | Mar 22, 2024 | $0.0361 |
| Dec 18, 2023 | Dec 22, 2023 | $0.0045 |
| Sep 24, 2018 | Sep 28, 2018 | $0.0017 |
| Dec 16, 2016 | Dec 30, 2016 | $0.0065 |
| Dec 24, 2014 | Dec 31, 2014 | $0.48 |
| Dec 19, 2014 | Dec 31, 2014 | $0.0092 |